Thyroid Hormones Affect Plasma Ghrelin and Obestatin Levels

Abstract

Using radioimmunoassay, the effects of thyroid hormones on plasma total ghrelin (Gh) and obestatin (Ob) concentrations were evaluated in thyrotoxic patients with an excess of thyroid hormones and in hypothyroid patients lacking endogenous thyroid hormones. 24 patients with thyrotoxicosis, 25 hypothyroid patents after total thyreoidectomy performed due to thyroid cancer, and 17 control subjects were examined. Compared with the controls, the ghrelin and obestatin were elevated in hypothyroidism, while they were decreased in thyrotoxicosis. The plasma Gh and Ob levels differ depending on the thyroid function. In thyroid hormones deficiency, plasma Gh and Ob are increased, while in patients with excess of thyroid hormones, the levels of both Gh and Ob are definitely lower. Gh/Ob ratio is higher in hypothyroidism than in control subjects and thyrotoxic patients.

thyroid hormones - ghrelin - obestatin

References

• 1 Kojima M, Hosoda H, Date Y, Nakazato M, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
• 2 Kojima M, Kangawa K. Structure and function of ghrelin.  Results Probl Cell Differ. 2008;  46 89-115
• 3 Suzuki K, Simpson KA, Minnion JS, Shillito JC, Bloom SR. The role of gut hormones and the hypothalamus in appetite regulation.  Endocr J. 2010;  57 359-372
• 4 Bednarek MA, Feighner SD, Pong SS, McKee KK, Hreniuk DL, Silva MV, Warren VA, Howard AD, Van Der Ploeg LH, Heck JV. Structure-function studies on the new growth-hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a.  J Med Chem. 2000;  43 4370-4376
• 5 Matsumoto M, , Kitajima Y, Iwanami T, Hayashi Y, Tanaka S, Minamitake Y, Hosoda H, Kojima M, Matsuo H, Kangawa K. Structural similarity of ghrelin derivatives to peptidyl growth hormone secretagogues.  Biochem Bioph Res Commun. 2001;  284 655-659
• 6 Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, Kangawa K. Ghrelin stimulates gastric acid secretion and motility in rats.  Biochem Bioph Res Commun. 2000;  276 905-908
• 7 Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Ueno N, Makino S, Fujimiya M, Niijima A, Fujino MA, Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.  Gastroenterology. 2001;  120 337-345
• 8 Cummings DE, Weigle DS, Scott Frayo R, Breen PA, Ma MK, Dellinger P, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.  NEJM. 2002;  346 1623-1630
• 9 Sedlackova D, Dostalova I, Hainer V, Beranova L, Kvasnickova H, Hill M, Haluzik M, Nedvidkova J. Simultaneous decrease of plasma obestatin and ghrelin levels after a high-carbohydrate breakfast in healthy women.  Physiol Res. 2008;  57 (S 01) S29-S37
• 10 Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by ghrelin gene, opposes ghrelin's effects on food intake.  Science. 2005;  310 (5750) 996-999
• 11 Nogueiras R, Pfluger P, Tovar S, Arnold M, Mitchell S, Morris A, Perez-Tilve D, Vázquez MJ, Wiedmer P, Castañeda TR, DiMarchi R, Tschöp M, Schurmann A, Joost HG, Williams LM, Langhans W, Diéguez C. Effects of obestatin on energy balance and growth hormone secretion in rodents.  Endocrinology. 2007;  148 21-26
• 12 Yamamoto D, Ikeshita N, Daito R, Hernongtyas EH, Toda K, Takahashi K, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats.  Regul Peptides. 2007;  138 141-144
• 13 Gourcerol G, Coskun T, Craft LS, Mayer JP, Heimann ML, Wang L, Million M, St-Pierre DH, Tache Y. Preprogherlin – derived peptide, obestatin, fails to influence food intake in lean or obese rodents.  Obesity. 2007;  15 2643-2652
• 14 Gourcerol G, Tache Y. Obestatin – a ghrelin-associated peptide that does not hold its promise to suppress food intake and motility.  Neurogastroent Motil. 2007;  19 161-165
• 15 Mondal M, Toshinai K, Ueno H, Koshinaka K, Nakazato M. Characterization of obestatin in rat and human stomach and plasma, and its lack of acute effect on feeding behavior in rodents.  J Endocrinol. 2008;  198 339-346
• 16 Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.  Eur J Endocrinol. 2006;  145 669-673
• 17 Monteleone P, Serritella C, Martiadis V, Scognamiglio P, Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not symptomatic patients with bulimia nervosa.  J Clin Endocrinol Metab. 2008;  93 4418-4421
• 18 Ngagya N, Uematsu M, Kojima M, Date Y, Nakazato M, Okumura H, Hosoda H, Shimizu W, Yamagishi M, Oya H, Koh H, Yutani C, Kangawa K. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationship between ghrelin and anabaoli/catabolic factors.  Circulation. 2001;  104 2034-2038
• 19 Butler MG, Bittel DC. Plasma obestatin and ghrelin levels in subjects with Prader-Willi syndrome.  Am J Med Gen. 2007;  143 415-421
• 20 Lippl F, Erdmann J, Lichter N, Tholl S, Wagenpfeil S, Adam O, Schusdziarra V. Relation of plasma obestatin levels to bmi, gender, age and insulin.  Horm Metab Res. 2008;  40 806-812
• 21 Zou CC, Liang L, Wang CL, Fu JF, Zhao ZY. The change in ghrelin and obestatin levels in obese children after weight reduction.  Acta Pediatr. 2009;  98 159-165
• 22 Qi X, Li L, Yang G, Liu J, Li K, Tang Y, Liou H, Boden G. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus.  Clin Endocrinol. 2007;  66 593-597
• 23 Garg A. The ongoing saga of obestatin: is it a hormone?.  J Clin Endocrinol Metab. 2007;  92 3396-3398
• 24 Dalkjaer Riis AL, Hansen TK, Moller N, Weeke J, Jorgensen JOL. Hyperthyroidism is associated with suppressed circulating ghrelin levels.  J Clin Endocrinol Metab. 2003;  88 853-857
• 25 Braclik M, Marcisz C, Giebel S, Orzeł A. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.  Thyroid. 2008;  18 545-550
• 26 Rojdmark S, Calissendorf J, Danielsson O, Brismar K. Hunger-satiety signals in patients with Graves’ thyrotoxicosis before, during, and after long-term pharmacological treatment.  Endocrine. 2005;  27 55-61
• 27 Gjedde S, Vestergaard ET, Gormsen LCh, Dalkjar Riis AL, Rungby J, Moller N, Weeke J, Jorgensen LOL. Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-Thyroxine treatment.  J Clin Endocrinol Metab. 2008;  93 2277-2280
• 28 Lass P, Sławek J, Derejko M, Rubello D. Neurological and psychiatric disorders in thyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging.  Minerva Endocrinol. 2008;  33 75-84

Correspondence